Al-Hadath translation – Baraa Badr
The University of Oxford and AstraZeneca announced the effectiveness of their vaccine in preventing many people from contracting the Coronavirus, and it has been proven to treat different age groups, including the elderly, and there are indications that it may also help stop the spread of the disease.
The University of Oxford said that the interim analysis from the vaccine trial in the third phase showed that the effectiveness of the vaccine is 70%, but that came from combining the results of two different dosing regimens, one of which was 90% and the other 62%.
“These results show that we have an effective vaccine that will save many lives,” said Professor Andrew Pollard, director of the Oxford Vaccine Group and chief researcher of the Oxford vaccine trial, in a press release.
He added that if people were given half a dose of the Oxford vaccine for the first time followed by a full dose a month later, they would enjoy up to 90% protection against the virus.
“The vaccine will be affordable and available globally, and hundreds of millions of doses will be provided upon approval,” said AstraZeneca CEO, Pascal Suriot.
It is expected to start administering the vaccine in the coming weeks if the vaccine is approved, as the United Kingdom has submitted requests for 100 million doses of the Oxford vaccine.
This vaccine is less convincing than the Pfizer / Biontech and our directors vaccines, whose effectiveness exceeds 90 percent, and even approaches 95 percent, but what distinguishes it is that it does not need to be stored at low temperatures.